Tenaya Therapeutics (TNYA) Preferred Shares Issued (2020 - 2021)
Tenaya Therapeutics' quarterly Preferred Shares Issued came in at -$5000.0 in Q2 2021, up 91.07% year-on-year from -$2616.8 in Q2 2020, and down 100.03% quarter-over-quarter from $20.0 million in Q1 2021.
Tenaya Therapeutics has reported Preferred Shares Issued for 2 years, with the latest figure at -$5000.0 in Q2 2021.
- For the quarter ending Q2 2021, Preferred Shares Issued rose 91.07% year-over-year to -$5000.0; the trailing twelve-month figure through Dec 2021 stood at $20.0 million (changed N/A YoY), and the FY2021 full-year result was $20.0 million, down 67.4% from the prior year.
- Preferred Shares Issued for Q2 2021 stood at -$5000.0, down from $20.0 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $86.0 million in Q4 2020, with the low at -$56000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenaya Therapeutics | 193.57 Mn | 193.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -5,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | 19.99 Mn |
| Mar 31, 2021 | 19.99 Mn |
| Dec 31, 2020 | 86.00 Mn |
| Dec 31, 2020 | 86.00 Mn |
| Sep 30, 2020 | 30.68 Mn |
| Sep 30, 2020 | 30.68 Mn |
| Jun 30, 2020 | -56,000.00 |
| Jun 30, 2020 | -56,000.00 |